Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
Bioorganic & Medicinal Chemistry
|
April 29, 2020
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity
Antonella Brizzi, Francesca Aiello, Serena Boccella, et al.
Chemmedchem
|
August 8, 2018
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain
Margherita Brindisi, Giuseppe Borrelli, Simone Brogi, et al.
European Journal of Medicinal Chemistry
|
May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
Clementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
European Journal of Medicinal Chemistry
|
January 19, 2023
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
Journal of Medicinal Chemistry
|
December 21, 2022
Development of <i>N</i>-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase
Francesca Intranuovo, Leonardo Brunetti, Pietro DelRe, et al.
ACS Chemical Neuroscience
|
September 19, 2018
FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic Drug
Alessia Ligresti, Cristoforo Silvestri, Rosa Maria Vitale, et al.
ACS Chemical Neuroscience
|
February 19, 2024
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, et al.
Cancer Biology & Therapy
|
September 23, 2015
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells
Donatella Fiore, Maria Chiara Proto, Simona Pisanti, et al.
European Journal of Medicinal Chemistry
|
October 15, 2010
Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands
Romano Silvestri, Alessia Ligresti, Giuseppe La Regina, et al.
ACS Chemical Neuroscience
|
March 5, 2016
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress
Francesca Aiello, Mariateresa Badolato, Federica Pessina, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
Bioorganic & Medicinal Chemistry
|
April 29, 2020
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity
Antonella Brizzi, Francesca Aiello, Serena Boccella, et al.
Chemmedchem
|
August 8, 2018
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain
Margherita Brindisi, Giuseppe Borrelli, Simone Brogi, et al.
European Journal of Medicinal Chemistry
|
May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
Clementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
European Journal of Medicinal Chemistry
|
January 19, 2023
N-adamantyl-anthranil amide derivatives: New selective ligands for the cannabinoid receptor subtype 2 (CB2R)
Giovanni Graziano, Pietro Delre, Francesca Carofiglio, et al.
Journal of Medicinal Chemistry
|
December 21, 2022
Development of <i>N</i>-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase
Francesca Intranuovo, Leonardo Brunetti, Pietro DelRe, et al.
ACS Chemical Neuroscience
|
September 19, 2018
FAAH-Catalyzed C-C Bond Cleavage of a New Multitarget Analgesic Drug
Alessia Ligresti, Cristoforo Silvestri, Rosa Maria Vitale, et al.
ACS Chemical Neuroscience
|
February 19, 2024
Novel Dual-Acting Hybrids Targeting Type-2 Cannabinoid Receptors and Cholinesterase Activity Show Neuroprotective Effects In Vitro and Amelioration of Cognitive Impairment In Vivo
Claudia Mugnaini, Antonella Brizzi, Marco Paolino, et al.
Cancer Biology & Therapy
|
September 23, 2015
Antitumor effect of pyrrolo-1,5-benzoxazepine-15 and its synergistic effect with Oxaliplatin and 5-FU in colorectal cancer cells
Donatella Fiore, Maria Chiara Proto, Simona Pisanti, et al.
European Journal of Medicinal Chemistry
|
October 15, 2010
Synthesis and biological evaluation of new N-alkyl 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides as cannabinoid receptor ligands
Romano Silvestri, Alessia Ligresti, Giuseppe La Regina, et al.
ACS Chemical Neuroscience
|
March 5, 2016
Design and Synthesis of New Transient Receptor Potential Vanilloid Type-1 (TRPV1) Channel Modulators: Identification, Molecular Modeling Analysis, and Pharmacological Characterization of the N-(4-Hydroxy-3-methoxybenzyl)-4-(thiophen-2-yl)butanamide, a Small Molecule Endowed with Agonist TRPV1 Activity and Protective Effects against Oxidative Stress
Francesca Aiello, Mariateresa Badolato, Federica Pessina, et al.
Page
of 12